Telegram RegisterThe public register of Telegram
Telegram profile photo for 찹츄만판당🎤

Channel

찹츄만판당🎤

@alienorinc

On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry

538subscribers

+3 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1002400675664
TypeChannel
Username@alienorinc
CreatedBetween 1 September 2024 and 31 March 2025 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded8 August 2026
Last confirmed live16 September 2026
Measurements held7
Confirmed unchanged1 time, most recently 16 September 2026
On Telegramt.me/alienorinc

Growth

535540537.57 August 2026 — 535 subscribers8 August 2026 — 535 subscribers16 August 2026 — 539 subscribers23 August 2026 — 535 subscribers30 August 2026 — 540 subscribers9 September 2026 — 536 subscribers16 September 2026 — 538 subscribers5387 August 202616 September 2026
7 measurements spanning 40 days, net +3. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 534–541 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
16 Sept 2026, 13:41538+2
9 Sept 2026, 03:57536-4
30 Aug 2026, 17:44540+5
23 Aug 2026, 10:46535-4
16 Aug 2026, 13:48539+4
8 Aug 2026, 03:49535no change
7 Aug 2026, 13:32535first reading

Engagement

16 posts held, back to 20 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 16 posts for this entry, the most recent from 2 August 2026. An engagement rate over an empty window would be a number about nothing.

Reaction mix

19 reactions across 7 posts, in 3 distinct kinds. The most used accounts for 47.4% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
947.4%
👍947.4%
😁15.26%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 8 of the 16 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 19 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 16 most recent posts we hold, published 20 July 2026 to 2 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

2 Aug 2026, 22:37 UTC190 views1 reactionsread 8 August 2026

엗? https://www.fnnews.com/news/202608030604117807

1

2 Aug 2026, 13:07 UTC251 viewsread 8 August 2026

비만약 마운자로·위고비, 오·남용 우려 의약품 지정 세계적으로 큰 인기를 끌고 있는 비만 치료제 마운자로는 터제파타이드 성분이다. 경쟁 제품인 위고비는 세마글루티드, 삭센다는 리라글루티드 성분이다. 식약처가 개정안을 고시하면 국내 시판 비만 치료제가 모두 오·남용 우려 의약품으로 분류된다. 식약처 관계자는 “지난 6월 이 개정안을 행정예고한 뒤 한 달여 기간 동안 전문가와 업계의 의견을 수렴했다”며 “내용을 바꿀 만한 이유를 찾지 못해 당초 계획했던 내용대로 고시할 예정”이라고 했다. 제약사는 약의 용기, 개별 포장, 첨부문서 등에 오·남용 우려 의약품 지정 사실을 알리는 경고 문구를 표기해야 한다. 정부가 ‘의약분업 예외 지역(병원이 없거나 드문 도서 산간 또는 읍·면 지역)’으로 지정한 곳에서는 원래 약사가 의사 처방 없이 전문의약품

2 Aug 2026, 12:12 UTC≈2,810 views1 reactionsread 8 August 2026
Photo

WCLC 2026 초록 타이틀 공개: VRN11 발표 미니오랄세션에서 VRN11 구두발표 예정 한 5분정도 간략하게 1상 결과+유효성 발표하는 세션. 발표 PI로는 안명주. + 같은 세션에서 전에 코멘트했던 BH-30643도 발표 예정 https://cattendee.abstractsonline.com/meeting/21487/Session/130

👍1

29 Jul 2026, 23:51 UTC326 views7 reactionsread 8 August 2026

이정도면 국민쇠퇴펀드아님? 미치셨는지...

👍7

29 Jul 2026, 23:51 UTC318 viewsread 8 August 2026
Forwarded from @anysong_Technon

https://www.hankyung.com/article/2026072938601 ????

29 Jul 2026, 12:28 UTC317 views3 reactionsread 8 August 2026

스파이더맨 후기: siRNA..으윽 여기서도..

2😁1

27 Jul 2026, 23:34 UTC296 viewsread 8 August 2026
Forwarded from @hkbioinsight

HLB, 10월 ESMO 2026서 리보세라닙·리라푸그라티닙 연구초록 3건 발표 https://www.hankyung.com/article/202607289522i

27 Jul 2026, 15:03 UTC264 viewsread 8 August 2026
Photo

엔테라 바이오, 2억 7,500만 달러 사모 발행으로 주가 급등 - ENTX +73%, 시가총액 1.87억 달러 기업이 2.75억 달러 사모발행으로 주가 급등 중/ 심지어 초과청약. - Longitude Capital, Vivo Capital, TCGX, Spruce Street Capital, Venrock Healthcare Capital Partners, RA Capital Management, Perceptive Advisors, Driehaus Capital Management, Logos Capital, Catalio Capital Management 참여. 굵직한 애들이 많이 눈에띔. - N-Tab은 위장에서 효소적인 분해를 막고 소장에서 투과성을 늘려 흡수를 늘리는 플랫폼 - 리드 파이프라인은 릴리의 골다공증 치료 주사

23 Jul 2026, 01:36 UTC316 views1 reactionsread 8 August 2026

왜 노바티스는 ADC에 뛰어들었나? - 컨콜에서 노바티스 CEO의 인수 코멘트를 요약한 내용. - 노바티스는 암종에 따라서 RLT보다 ADC가 더 낫다는걸 알고 있었는데 경쟁이 포화된 시장에 차별점을 못찾음. - Payload가 이 차별점으로 Topo i 이나 튜뷸린 계열로 진입해봐야 의미없다고 판단. - 그래서 Myricx의 NMT가 엄청 매력적. topo1이나 튜불린 내성에 모두 접근 가능했고 안전성도 높았음. - 이제 새로운 후발주자라고 봐야하는 그룹은 결국 payload로 이목이 쏠리는 중. DAC도 결국 페이로드 얘기고, STING agonist 얘기도 나옴. - novel payload전략이 dual payload보다 낫다고 판단하는 것 같음. dual은 결국 한쪽은 기존 payload니까 약간 안전마진을 가져가고싶은 느

1

21 Jul 2026, 14:41 UTC338 views1 reactionsread 8 August 2026

https://www.fiercebiotech.com/research/nobel-laureate-jennifer-doudna-enters-ai-protein-design-arena?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotechResearch&oly_enc_id=7542C6767501F7L CRISPR 노벨상 수상자 제니퍼 도드나 AI를 이용해 새로운 유전자편집 효소 개발 - cas9의 조상격이지만 더작고 잘듣는 가위 개발. TnpB라고함 - Ai가 특이적인 효소 개발이 가능하도록 디자인을 도울 수 있음 - 다른 노벨수상자인 베이커와 긴밀하게 협업중 특이점이 온당..

👍1

21 Jul 2026, 02:02 UTC246 viewsread 8 August 2026
Forwarded from @thebio111

지투지바이오는 의료·바이오 인공지능(AI) 스타트업인 스파이더코어와 장기지속형 주사제 개발을 위한 ‘AI 기반 연구개발(R&D) 플랫폼 구축 계약’을 체결했다고 밝혔습니다. 이번 계약은 장기지속형 미립구 제형과 공정 개발 과정에서 축적된 데이터를 AI가 학습해 최적의 제형 조합과 공정 분석 자동화 플랫폼을 구축하기 위해 체결됐습니다. 지투지바이오는 AI 플랫폼을 활용해 장기지속형 주사제 개발 속도를 2배 이상 높이고 관련 비용을 50% 이상 줄이는 것을 목표로 하고 있습니다. 향후 2년 안에 플랫폼을 연구 현장에 적용해 연구원 1인당 수행 가능한 프로젝트 수를 최대 4개까지 확대할 계획입니다. 새 플랫폼은 지투지바이오가 보유한 연구 데이터와 국내외 공개 논문·특허 정보를 통합해 분석합니다. 이를 기반으로 목표로 하는 체내 약물 농도 변화

Showing the 12 most recent of 16 posts we hold for @alienorinc. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 16 September 2026 — this entry's latest reading, not the date you are reading this.

“찹츄만판당🎤” (@alienorinc), 538 subscribers as measured 16 September 2026. Telegram Register, tgregister.com/channel/alienorinc.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.